These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33454878)

  • 1. Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy.
    Nakanishi R; Oki E; Hasuda H; Sano E; Miyashita Y; Sakai A; Koga N; Kuriyama N; Nonaka K; Fujimoto Y; Jogo T; Hokonohara K; Hu Q; Hisamatsu Y; Ando K; Kimura Y; Yoshizumi T; Mori M
    Ann Surg Oncol; 2021 Jun; 28(6):2975-2985. PubMed ID: 33454878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
    Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
    Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy.
    Qi W; Yang J; Zheng L; Lu Y; Liu R; Ju Y; Niu T; Wang D
    Med Phys; 2023 May; 50(5):2705-2714. PubMed ID: 36841949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging-radiomics evaluation of response to chemotherapy for synchronous liver metastasis of colorectal cancer.
    Ma YQ; Wen Y; Liang H; Zhong JG; Pang PP
    World J Gastroenterol; 2021 Oct; 27(38):6465-6475. PubMed ID: 34720535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases.
    Taghavi M; Trebeschi S; Simões R; Meek DB; Beckers RCJ; Lambregts DMJ; Verhoef C; Houwers JB; van der Heide UA; Beets-Tan RGH; Maas M
    Abdom Radiol (NY); 2021 Jan; 46(1):249-256. PubMed ID: 32583138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy.
    Ye S; Han Y; Pan X; Niu K; Liao Y; Meng X
    Front Oncol; 2022; 12():843991. PubMed ID: 35692757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-Based Radiomics Analysis Before Thermal Ablation to Predict Local Tumor Progression for Colorectal Liver Metastases.
    Taghavi M; Staal F; Gomez Munoz F; Imani F; Meek DB; Simões R; Klompenhouwer LG; van der Heide UA; Beets-Tan RGH; Maas M
    Cardiovasc Intervent Radiol; 2021 Jun; 44(6):913-920. PubMed ID: 33506278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A predictive model for early therapeutic efficacy of colorectal liver metastases using multimodal MRI data.
    Su X; Zhang H; Wang Y
    J Xray Sci Technol; 2023; 31(2):357-372. PubMed ID: 36591694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy.
    Ravanelli M; Agazzi GM; Tononcelli E; Roca E; Cabassa P; Baiocchi G; Berruti A; Maroldi R; Farina D
    Radiol Med; 2019 Sep; 124(9):877-886. PubMed ID: 31172448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway.
    Dercle L; Lu L; Schwartz LH; Qian M; Tejpar S; Eggleton P; Zhao B; Piessevaux H
    J Natl Cancer Inst; 2020 Sep; 112(9):902-912. PubMed ID: 32016387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting response to neoadjuvant chemotherapy for colorectal liver metastasis using deep learning on prechemotherapy cross-sectional imaging.
    Davis JMK; Niazi MKK; Ricker AB; Tavolara TE; Robinson JN; Annanurov B; Smith K; Mantha R; Hwang J; Shrestha R; Iannitti DA; Martinie JB; Baker EH; Gurcan MN; Vrochides D
    J Surg Oncol; 2024 Jul; 130(1):93-101. PubMed ID: 38712939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer.
    Roll W; Masthoff M; Köhler M; Rahbar K; Stegger L; Ventura D; Morgül H; Trebicka J; Schäfers M; Heindel W; Wildgruber M; Schindler P
    Cardiovasc Intervent Radiol; 2024 Apr; 47(4):462-471. PubMed ID: 38416178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT radiomics models are unable to predict new liver metastasis after successful thermal ablation of colorectal liver metastases.
    Taghavi M; Staal FC; Simões R; Hong EK; Lambregts DM; van der Heide UA; Beets-Tan RG; Maas M
    Acta Radiol; 2023 Jan; 64(1):5-12. PubMed ID: 34918955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.
    Nie P; Yang G; Guo J; Chen J; Li X; Ji Q; Wu J; Cui J; Xu W
    Cancer Imaging; 2020 Feb; 20(1):20. PubMed ID: 32093786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comprehensive Machine Learning Benchmark Study for Radiomics-Based Survival Analysis of CT Imaging Data in Patients With Hepatic Metastases of CRC.
    Stüber AT; Coors S; Schachtner B; Weber T; Rügamer D; Bender A; Mittermeier A; Öcal O; Seidensticker M; Ricke J; Bischl B; Ingrisch M
    Invest Radiol; 2023 Dec; 58(12):874-881. PubMed ID: 37504498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy.
    Wei S; Han Y; Zeng H; Ye S; Cheng J; Chai F; Wei J; Zhang J; Hong N; Bao Y; Zhou J; Ye Y; Meng X; Zhou Y; Deng Y; Qiu M; Tian J; Wang Y
    Eur J Radiol; 2021 Sep; 142():109863. PubMed ID: 34343846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the computed tomography texture analysis of colorectal liver metastases predict the response to first-line cytotoxic chemotherapy?
    Rabe E; Cioni D; Baglietto L; Fornili M; Gabelloni M; Neri E
    World J Hepatol; 2022 Jan; 14(1):244-259. PubMed ID: 35126852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.
    Liu A; Wang Z; Yang Y; Wang J; Dai X; Wang L; Lu Y; Xue F
    Cancer Commun (Lond); 2020 Jan; 40(1):16-24. PubMed ID: 32125097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflection: Radiomics-Based Prediction for the Responder to First-Line Oxaliplatin-Based Chemotherapy in Patients with Colorectal Liver Metastasis.
    Nakanishi R; Oki E; Hasuda H; Sano E; Miyashita Y; Sakai A; Koga N; Kuriyama N; Nonaka K; Fujimoto Y; Jogo T; Hokonohara K; Hu Q; Hisamatsu Y; Ando K; Kimura Y; Yoshizumi T; Mori M
    Ann Surg Oncol; 2021 Jun; 28(6):2986-2987. PubMed ID: 33725205
    [No Abstract]   [Full Text] [Related]  

  • 20. Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases.
    Giannini V; Pusceddu L; Defeudis A; Nicoletti G; Cappello G; Mazzetti S; Sartore-Bianchi A; Siena S; Vanzulli A; Rizzetto F; Fenocchio E; Lazzari L; Bardelli A; Marsoni S; Regge D
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.